Alliance Pharma PLC (STU:DVL)
€ 0.52 0.005 (0.97%) Market Cap: 296.49 Mil Enterprise Value: 400.78 Mil PE Ratio: 0 PB Ratio: 1.12 GF Score: 75/100

Half Year 2019 Alliance Pharma PLC Earnings Call Transcript

Sep 24, 2019 / 09:00AM GMT
Release Date Price: €0.83 (+2.47%)
Peter Jonathan Butterfield
Alliance Pharma plc - CEO & Executive Director

Okay. Good morning, everybody, and welcome to everybody online who's joining us for our interim results. I'm Pete Butterfield, CEO of Alliance Pharma. I'm joined today by Andrew Franklin, our CFO.

So very pleased to take you through our first 6 months of trading. Just in terms of the agenda this morning, as always, we'll give you a quick business overview. I think everybody in the room is relatively familiar with Alliance's story, but I know we're joined online by some new people. So just to take you very quickly through a business overview. Andy is going to talk in-depth about the numbers and H1 results. Then we're going to look at the brands in a bit more detail, what are the key drivers in each of the markets as we've discussed. And just to give you an update on how each of those are performing. And then we'll end with a very quick summary. But as always, happy to take questions at the end. And hopefully, we'll leave a bit of time for that this time.

So yes, very pleased to be able to stand here today,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot